Medi Assist Upgrades AI Platform to Boost Cashless Healthcare: Over 50% of Pre-Authorisations Processed in Under Five Minutes

Medi Assist Upgrades AI Platform to Boost Cashless Healthcare: Over 50% of Pre-Authorisations Processed in Under Five Minutes

Medi Assist Upgrades AI Platform to Boost Cashless Healthcare: Over 50% of Pre-Authorisations Processed in Under Five Minutes​

Medi Assist Healthcare Services Limited has announced significant technological enhancements across its AI platform, making a major stride toward seamless cashless healthcare for patients, hospitals, and insurers. The upgrades include the release of MAven Intelligent Document Processing (MAven IDP), MAgnum, and MAven Guard, bolstering the company's commitment to accessibility in the health benefits administration space.

The results of these advancements are already yielding measurable improvements within the organization’s operations. Medi Assist TPA, a wholly owned subsidiary, now processes over 50% of cashless pre-authorisations in under five minutes. This speed enhancement is designed to enable patients to be admitted and commence treatment faster.

Key performance indicators (KPIs) related to this improved claims experience include:
  • Net Promoter Score (NPS): The enhanced service has achieved an NPS of 67, reflecting improvements in consistency and member satisfaction.
  • Claimant Calls: Calls from claimants have reportedly dropped by over 60%, indicating a smoother and more efficient claims journey.

Satish Gidugu, CEO of Medi Assist Group, stated that the company believes technology must make healthcare accessible, not complicated. He emphasized that their focus is extending their approach—which began by simplifying discharge processes with Raksha Prime—across the entire cashless journey, covering admission, authorization, and fraud detection.

Platform Enhancements Drive Efficiency and Integrity​

Each new platform release targets a specific stage of the cashless care pathway:

Faster Authorisations via MAven IDP:
MAven IDP, Medi Assist's AI-enabled document processor, is designed to read and standardize hospitalisation documents into structured clinical summaries. This provides claims teams with necessary context for faster and consistent decision making, accelerating patient admissions.

Greater Transparency through MAgnum:
MAgnum enables hospitals to view in real time whether a patient qualifies for Raksha Prime. The platform also details the status of every claim and specifies which cases have been settled and paid. This transparency allows hospitals to offer cashless treatment with fewer queries and faster admissions.

Stronger Claims Integrity with MAven Guard:
The new release of MAven Guard focuses on protecting the ecosystem by detecting fraud, waste, and abuse with up to 50% greater precision, while ensuring genuine claims continue moving quickly.

In a significant expansion move, Medi Assist announced that MAven IDP is now available beyond the internal Medi Assist Group for insurers and healthcare providers, expanding its influence across the Indian cashless care ecosystem. These advancements collectively work towards a future where admission is immediate, authorization is near-instantaneous, and trust is integrated into every claim.

Medi Assist Healthcare Services Limited provides comprehensive health benefits administration services and technology platforms to the insurance sector. Through Medi Assist TPA, the company acts as a facilitator among insurance companies, policyholders, healthcare providers (like hospitals), and beneficiaries of public health schemes.

MEDIASSIST Stock Price Movement​

As of 3:23 PM, Medi Assist Healthcare Services Limited is shedding approximately 1.08% in live trading, slipping ₹3.90 and currently finding a value around ₹357.5. The stock has seen brisk movement today, with over 143,671 shares recorded in the trade volume.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top